Mindset Pharma Inc., headquartered in Toronto, Canada, specializes in researching, developing, and commercializing psychedelic therapeutics. These innovative treatments are designed to address neurological and psychiatric conditions for patients in Canada. A primary focus for the company is the ongoing development of MSP-1014, an investigational psychedelic compound.